A pioneering test could be used to predict whether breast cancer will return. Patients with clustered immune cells, called hotspot were 25 per cent more likely to relapse within 10 years.
The probability of the cancer returning within five years was 23 per cent higher in women with the hotspot. The new method gives doctors the opportunity to provide better preventative drugs to prevent the cancer.
The automated computer tool made an assessment of the risk of relapse based on how cells are organised spatially.
People with dispersed immune cells have better chance of fending off the cancer.
Pioneering test also predict patients that will respond to immunotherapy.
The immune system has a key role to play in how breast cancer responds to hormone treatment.
Measuring the immune response to cancer could be important in the future to identify patients who could benefit from immunotherapy. The immune tool could be added to existing prognostic tests to identify women that are at high risk of their breast cancer coming back.
haleplushearty.blogspot.com.
No comments:
Post a Comment